These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 18441900)

  • 21. Synthesis of a new antischistosomally active and toxicologically tolerant C-12 monothione surrogate of the universal antihelmintic praziquantel.
    Abo-Ghalia MH; Soliman AM
    Acta Pol Pharm; 2002; 59(4):313-20. PubMed ID: 12403307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Observations on the histopathological changes of Schistosoma japonicum and host liver caused by pyquiton in experimental chemotherapy (author's transl)].
    Yang YQ; Yang HZ; Xiao SH; Shao BR; Tang XM; Zhu ZG; Zhang HX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1979 Sep; 1(1):7-12. PubMed ID: 262815
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins.
    Xiao SH
    Acta Trop; 2005; 96(2-3):153-67. PubMed ID: 16112072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs for the control of parasitic diseases: current status and development in schistosomiasis.
    Fenwick A; Savioli L; Engels D; Robert Bergquist N; Todd MH
    Trends Parasitol; 2003 Nov; 19(11):509-15. PubMed ID: 14580962
    [No Abstract]   [Full Text] [Related]  

  • 25. Praziquantel derivatives exhibit activity against both juvenile and adult Schistosoma japonicum.
    Duan WW; Qiu SJ; Zhao Y; Sun H; Qiao C; Xia CM
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1587-90. PubMed ID: 22264473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.
    Doenhoff MJ; Hagan P; Cioli D; Southgate V; Pica-Mattoccia L; Botros S; Coles G; Tchuem Tchuenté LA; Mbaye A; Engels D
    Parasitology; 2009 Nov; 136(13):1825-35. PubMed ID: 19281637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-schistosomal drug praziquantel is an adenosine antagonist.
    Angelucci F; Basso A; Bellelli A; Brunori M; Pica Mattoccia L; Valle C
    Parasitology; 2007 Aug; 134(Pt 9):1215-21. PubMed ID: 17428352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schistosomiasis chemotherapy.
    Thétiot-Laurent SA; Boissier J; Robert A; Meunier B
    Angew Chem Int Ed Engl; 2013 Jul; 52(31):7936-56. PubMed ID: 23813602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents.
    Yang JJ; Boissier J; Chen JL; Yao H; Yang S; Rognon A; Qiao C
    Future Med Chem; 2015; 7(6):713-25. PubMed ID: 25996065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research progress of the evaluation methods on the resistance of schistosome to praziquantel].
    Guo J; Guo JG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Jun; 23(3):182-4. PubMed ID: 16300016
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of praziquantel and artesunate on the tegument of adult Schistosoma mekongi harboured in mice.
    Jiraungkoorskul W; Sahaphong S; Sobhon P; Riengrojpitak S; Kangwanrangsan N
    Parasitol Int; 2005 Sep; 54(3):177-83. PubMed ID: 15925540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward organometallic antischistosomal drug candidates.
    Hess J; Keiser J; Gasser G
    Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schistosomiasis and pregnancy.
    Friedman JF; Mital P; Kanzaria HK; Olds GR; Kurtis JD
    Trends Parasitol; 2007 Apr; 23(4):159-64. PubMed ID: 17336160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
    Doenhoff MJ; Cioli D; Utzinger J
    Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of praziquantel resistance in schistosomes.
    Liang YS; Coles GC; Doenhoff MJ
    Trop Med Int Health; 2000 Jan; 5(1):72. PubMed ID: 10672208
    [No Abstract]   [Full Text] [Related]  

  • 36. Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis.
    Lee EF; Fairlie WD
    Future Med Chem; 2015; 7(6):707-11. PubMed ID: 25996064
    [No Abstract]   [Full Text] [Related]  

  • 37. Will new antischistosomal drugs finally emerge?
    Cioli D; Valle C; Angelucci F; Miele AE
    Trends Parasitol; 2008 Sep; 24(9):379-82. PubMed ID: 18675590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [(η(6)-Praziquantel)Cr(CO)3] derivatives with remarkable in vitro anti-schistosomal activity.
    Patra M; Ingram K; Pierroz V; Ferrari S; Spingler B; Gasser RB; Keiser J; Gasser G
    Chemistry; 2013 Feb; 19(7):2232-5. PubMed ID: 23296750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens.
    Mutapi F; Burchmore R; Mduluza T; Foucher A; Harcus Y; Nicoll G; Midzi N; Turner CM; Maizels RM
    J Infect Dis; 2005 Sep; 192(6):1108-18. PubMed ID: 16107967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histone deacetylase and histone acetyltransferase inhibitors as antischistosomal agents: a review].
    Wang Y; Xu J; Xia C
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2024 Mar; 36(2):207-214. PubMed ID: 38857968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.